CIK 0001514183 · Non-accelerated filer<br>Smaller reporting company
Silo Pharma, Inc.
Sign in to watch- Ticker
- SILO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462137136
- Phone
- (718) 400-9031
- Business address
- 677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
- Former names
- Uppercut Brands, Inc., Point Capital, Inc., Gold Swap Inc
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $0.42 ($2,075)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $0.37 ($735)
- 4 Open-market buy Chief Executive Officer bought 12,000 shares at an average $0.40 ($4,847)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $0.43 ($4,329)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO and President bought 2,500 shares at $0.84 ($2,097)
- 4 Open-market buy CEO and President bought 5,000 shares at an average $0.93 ($4,625)
- 4 Open-market buy CEO and President bought 5,000 shares at an average $1.11 ($5,533)
- 4 Open-market buy CEO and President bought 1,000 shares at an average $1.99 ($1,988)
- 4 Open-market buy CEO and President bought 4,508 shares at an average $1.93 ($8,713)
- 4 Open-market buy CEO and President bought 700 shares at an average $1.62 ($1,137)
- 4 Open-market buy CEO and President bought 1,100 shares at an average $1.52 ($1,668)
- 4 Open-market buy CEO and President bought 1,000 shares at an average $1.38 ($1,376)
- 4 Open-market buy CEO and President bought 2,000 shares at an average $1.55 ($3,100)
- 4 Open-market buy CEO and President bought 650 shares at an average $1.72 ($1,117)
- 4 Open-market buy CEO and President bought 4,350 shares at an average $1.60 ($6,948)
Page 1 of 3 · 58 filings